{
    "code": "10000911",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000911",
    "time": "2019-06-21 03:06:54",
    "許可證字號": "衛署菌疫輸字第000911號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/06\/11",
    "發證日期": "100\/06\/11",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000091101",
    "中文品名": "欣普尼 注射液",
    "英文品名": "Simponi (golimumab),Solution for Injection",
    "適應症": "類風濕性關節炎:欣普尼SIMPONI與methotrexate併用適用於治療中至重度活動性類風濕性關節炎成人患者。僵直性脊椎炎:欣普尼SIMPONI適用於治療活動性僵直性脊椎炎成人患者。乾癬性關節炎:欣普尼SIMPONI單獨使用或與methotrexate併用適用於治療對疾病修飾性抗風濕藥物(DMARDs)無效之活動性乾癬性關節炎成人患者。潰瘍性結腸炎:欣普尼SIMPONI適用於對於皮質類固醇和6-mercaptopurine (6-MP)或azathioprine (AZA)等傳統治療無效、或對這種療法不耐受或有醫療禁忌之中度至嚴重活動性潰瘍性結腸炎成人病患",
    "劑型": "270注射劑",
    "包裝": "0.5公撮注射針筒 自動注射器（SmartJect autoinjector） 1.0公撮注射針筒 自動注射器（SmartJect autoinjector）",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "Golimumab",
    "主製造廠": {
        "申請商名稱": "1507401100  嬌生股份有限公司",
        "申請商地址": "台北市中山區民生東路三段2號10樓及11樓",
        "主製造廠": "",
        "製造廠名稱": "FCH0015000  CILAG AG."
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "委託包裝廠(貼標)"
        },
        {
            "製造廠名稱": "FCH0263000  CILAG AG",
            "製造廠廠址": "HOCHSTRASSE 201, CH-8200 SCHAFFHAUSEN, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FIE0080000  JANSSEN SCIENCES IRELAND UC",
            "製造廠廠址": "BARNAHELY, RINGASKIDDY, CO.CORK, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "主成分(drug substance)製造廠"
        },
        {
            "製造廠名稱": "FNL0059000  JANSSEN BIOLOGICS B.V.",
            "製造廠廠址": "EINSTEINWEG 101, 2333 CB LEIDEN, THE NETHERLANDS",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": "主成分(drug substance)製造廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013002900",
            "成分名稱": "Golimumab",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "欣普尼注射液_仿單v1901新址_20190312-108-04-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000911&Seq=019&Type=9"
        },
        {
            "title": "Simponi 100mg Baxter Label_36736A-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000911&Seq=027&Type=8"
        },
        {
            "title": "Simponi 50mg Baxter Label_35762B-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000911&Seq=026&Type=8"
        },
        {
            "title": "Simponi 100mg Cilag Label_38259A-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000911&Seq=025&Type=8"
        },
        {
            "title": "Simponi 50mg Cilag Label_38257A-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000911&Seq=024&Type=8"
        },
        {
            "title": "0420-35762A Hi-106-05-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000911&Seq=015&Type=8"
        },
        {
            "title": "0411-35759B Hi-106-05-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000911&Seq=014&Type=8"
        },
        {
            "title": "0410-36731A Hi-106-05-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000911&Seq=013&Type=8"
        }
    ]
}